Ye Pengfei, Xi Yue, Huang Zhiying, Xu Pengfei
College of Clinical Medicine, Henan University of Science and Technology, Luoyang 471003, China.
Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Cancers (Basel). 2020 May 29;12(6):1408. doi: 10.3390/cancers12061408.
The incidence of obesity and colorectal cancer (CRC) has risen rapidly in recent decades. More than 650 million obese and 2 billion overweight individuals are currently living in the world. CRC is the third most common cancer. Obesity is regarded as one of the key environmental risk factors for the pathogenesis of CRC. In the present review, we mainly focus on the epidemiology of obesity and CRC in the world, the United States, and China. We also summarize the molecular mechanisms linking obesity to CRC in different aspects, including nutriology, adipokines and hormones, inflammation, gut microbiota, and bile acids. The unmet medical needs for obesity-related CRC are still remarkable. Understanding the molecular basis of these associations will help develop novel therapeutic targets and approaches for the treatment of obesity-related CRC.
近几十年来,肥胖症和结直肠癌(CRC)的发病率迅速上升。目前全球有超过6.5亿肥胖者和20亿超重者。结直肠癌是第三大常见癌症。肥胖被认为是结直肠癌发病机制的关键环境风险因素之一。在本综述中,我们主要关注全球、美国和中国肥胖症和结直肠癌的流行病学。我们还从营养学、脂肪因子和激素、炎症、肠道微生物群和胆汁酸等不同方面总结了肥胖与结直肠癌之间的分子机制。肥胖相关结直肠癌尚未满足的医疗需求仍然显著。了解这些关联的分子基础将有助于开发治疗肥胖相关结直肠癌的新治疗靶点和方法。